• By Meagan Farmer
  • Posted October 18, 2023

Breast Cancer Awareness Month: CHEK2 with Petra Kleiblova and Zdenek Kleibl

Amby Genetics is proud to have worked with a large international team on clarifying the significance of CHEK2 variants. We connected with team leaders Dr. Petra Kleiblova and Dr. Zdenek Kleibl ahead of Breast Cancer Awareness Month. They provided us with the following commentary on the importance of the recent publication, “ENIGMA CHEK2gether…


  • By Jaime Burguieres
  • Posted September 29, 2022

An Attitude of Gratitude: Jaime Burguieres’ Previvor Cancer Journey Guided by Ambry Genetic Testing

When Jaime Burguieres was young, her 43-year-old maternal aunt was diagnosed with breast cancer. Burguieres watched her vivacious aunt go through painful radiation and chemotherapy treatments that seemingly eradicated her cancer at the time. A few years later, her aunt was diagnosed with Non-Hodgkin’s Lymphoma in the breast, stomach, and hip,…


  • By Deepti Babu, MS, CGC
  • Posted April 14, 2017

Ambry Genetics and Leading Academic Researchers Collaborate to Improve Knowledge of Genetic Risk Factors for Breast Cancer

New clinical evidence collected from >65,000 women with breast cancer demonstrates 83% of positive test results are found in genes that impact clinical management Multi-gene germline genetic testing allows for efficient analysis, maximizing risk assessment while minimizing the time needed for results. This has been particularly effective…


  • By Deepti Babu, MS, CGC
  • Posted December 23, 2016

New Research on Male Breast Cancer: Unexpected Results and Insights

Breast cancer in men may be rare in the average population, but is far more common in people with an underlying genetic predisposition. Finding a cancer gene mutation in a man with breast cancer can drastically impact medical management for him and his family members (who may otherwise not be screened for the disease). Current guidelines recommend…


  • By Jackie Connor
  • Posted December 14, 2016

Dr. Fergus Couch Talks with Ambry about Recent Study Findings

At Ambry we had the exciting opportunity to talk with Dr. Fergus Couch, Mayo Clinic Researcher, about his involvement with our Mayo Clinic research collaboration. “Breast cancer risks associated with mutations in cancer predisposition genes identified by clinical genetic testing of 60,000 breast cancer patients,” which was the largest hereditary…